Saturday, 28 May 2022

 

 

LATEST NEWS Army vehicle fell into Shyok river Ladakh, 7 killed & several injured Decision to sell land adjacent to Patiala's historical Shri Kedarnath temple completely anti-people : Preneet Kaur The Title Of Akshay Kumar & Manushi Chhillar’s Prithviraj Changed. View Inside Punjab Increases Rates Of Group Insurance Scheme For Govt Employees 7 soldiers killed, 19 injured in Ladakh road accident IPL 2022: Things are falling in place for Royal Challengers Bangalore, says Sanjay Manjrekar French Open : Diego Schwartzman dispatches Grigor Dimitrov, moves to fourth round Deepika Padukone shares heartwarming 'Period Story' to raise awareness PWD Minister Harbhajan Singh ETO conducts surprise checking at Sector 17 offices of department Launch mass movement to save water : Punjab Chief Minister Bhagwant Mann Bollywood Stars Come Forward For The Promotions Of Qureshi Productions' DEHATI DISCO; Now in theatres Test cricket on downward trend, England can really change it : Brendon McCullum Smriti Irani slams Gandhis, says chants of 'Shri Ram' must reach them Udit Narayan shares his experience watching Anuradha Paudwal sing for the first time SS Rajamouli releases glimpse of 'Brahmastra's first song I will consider myself lucky to die alone : Samantha Ruth Prabhu in response to a troll IPL 2022 : Faf du Plessis, Virat Kohli, Glenn Maxwell will have to score runs for Royal Challengers Bangalore to win against Rajasthan Royals, says Akash Chopra Akshay Kumar : I have done almost 650 songs in my career, and I don't ever want to retire Daniel Bruhl, Macaulay Culkin join pandemic thriller 'Rich Flu' Zayn Ibad Khan, Khushi Dubey open up on being part of Hotstar Specials 'Aashiqana' 'The Broken News' trailer exposes gritty reality of the news business

 

Prior Covid infection may help vaccine fight new variants

Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Corona Virus Updates, Coronavirus Epidemic, Coronavirus Pandemic, Corona virus threat , Corona Outbreak, Covid-19 pandemic, Covaxin, Covishield, Covid-19 Vaccine,COVID-19 Vaccination, COVID Vaccination, SARS-CoV-2, Pfizer/BioNTech vaccines

Web Admin

Web Admin

5 Dariya News

London , 02 May 2021

A single dose of Pfizer/BioNTech vaccines against Covid may boost immunity against the coronavirus variants, only in people who were previously infected with the deadly virus, a study has found, highlighing the importance of a second dose.In people who have not previously been infected and have so far only received one dose of vaccine, the immune response to variants of concern may be insufficient, said the team of researchers at Imperial College London, Queen Mary University of London and University College London.The study, published in the journal Science, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vaccine.People who had previously had mild or asymptomatic infection had significantly enhanced protection against the UK and South Africa variants, after a single dose of the mRNA vaccine.In those without prior Covid-19, the immune response was less strong after a first dose, potentially leaving them at risk from variants."Our findings show that people who have had their first dose of vaccine, and who have not previously been infected with SARS-CoV-2, are not fully protected against the circulating variants of concern," said Rosemary Boyton, Professor of Immunology and Respiratory Medicine at Imperial College."This study highlights the importance of getting second doses of the vaccine rolled out to protect the population," Boyton added. Blood samples were analysed for the presence and levels of immunity against the original strain of SARS-CoV-2, as well as the UK (B117) and South Africa (B1351) variants of concern. Along with antibodies, the team also focused on two types of white blood cells: B-cells, which 'remember' the virus; and T cells, which help B cell memory and recognise and destroy cells infected with coronavirus.They found that after a first dose of vaccine, prior infection was associated with a boosted T cell, B cell and neutralising antibody response, which could provide effective protection against SARS-CoV-2, as well as the UK and South Africa variants.However, in people without previous SARS-CoV-2 infection, a single vaccine dose resulted in lower levels of neutralising antibodies against SARS-CoV-2 and the variants, potentially leaving them vulnerable to infection and highlighting the importance of the second vaccine dose.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Covid-19 pandemic , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , SARS-CoV-2 , Pfizer/BioNTech vaccines

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD